Literature DB >> 20427782

Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography.

Zuo-Feng Xu1, Hui-Xiong Xu, Xiao-Yan Xie, Guang-Jian Liu, Yan-Ling Zheng, Ming-De Lu.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the usefulness of contrast-enhanced ultrasonography (CEUS) in differentiating renal cell carcinoma (RCC) from renal angiomyolipoma (RAML).
METHODS: One hundred nineteen patients with 126 renal lesions (33 RAMLs and 93 RCCs) who had undergone CEUS were retrospectively studied. All of the lesions were histopathologically or clinical proved. Contrast-enhanced ultrasonography was performed using low-acoustic power modes and a sulfur hexafluoride-filled microbubble contrast agent. The baseline sonograms and CEUS images were retrospectively analyzed in consensus by 2 radiologists. The tumor echogenicity, enhancement patterns, and degree of enhancement at different phases were evaluated. The diagnostic efficacy of CEUS in differentiating the two diseases was computed and compared.
RESULTS: On CEUS, the features of wash-out from hyperenhancement or isoenhancement to hypoenhancement over time (observed in 3.0% of RAMLs and 71.0% of RCCs; P < .001), heterogeneous enhancement (observed in 12.1% of RAMLs and 74.2% of RCCs; P < .001), and an enhanced perilesional rim (observed in 3.0% of RAMLs and 79.6% of RCCs; P < .001) achieved significant difference between RCCs and RAMLs. Early wash-out and heterogeneous enhancement or peritumoral rim enhancement yielded the highest diagnostic capability in differentiating RCC from RAML. The corresponding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 88.2% (82 of 93), 97.0% (32 of 33), 98.8% (82 of 83), 74.4% (32 of 43), and 90.5% (114 of 126), respectively.
CONCLUSIONS: The CEUS features of early wash-out, heterogeneous enhancement, and an enhanced peritumoral rim highly suggest RCC, whereas homogeneous enhancement and prolonged enhancement are characteristic manifestations of RAML. Contrast-enhanced ultrasonography is valuable in differentiating RCC from RAML.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427782     DOI: 10.7863/jum.2010.29.5.709

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  32 in total

Review 1.  Management of incidental renal masses: Time to consider contrast-enhanced ultrasonography.

Authors:  Francesca Di Vece; Paola Tombesi; Francesca Ermili; Sergio Sartori
Journal:  Ultrasound       Date:  2016-01-14

2.  Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging.

Authors:  Marybeth A Pysz; Ismayil Guracar; Kira Foygel; Lu Tian; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2012-04-26       Impact factor: 9.596

3.  Era of diagnostic and interventional ultrasound.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2011-05-28

Review 4.  Contrast-enhanced ultrasound of the kidneys and adrenals in children.

Authors:  Susan J Back; Patricia T Acharya; Richard D Bellah; Harris L Cohen; Kassa Darge; Annamaria Deganello; Zoltan Harkanyi; Damjana Ključevšek; Aikaterini Ntoulia; Harriet J Paltiel; Maciej Piskunowicz
Journal:  Pediatr Radiol       Date:  2021-05-12

5.  Evaluation of renal masses with contrast-enhanced ultrasound: initial experience.

Authors:  Scott Gerst; Lucy E Hann; Duan Li; Mithat Gonen; Satish Tickoo; Michael J Sohn; Paul Russo
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

6.  [Incidental findings in abdominal ultrasound. Characteristics and clinical interpretation].

Authors:  C Görg; S Kunsch; A Neesse
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

Review 7.  The clinical use of contrast-enhanced ultrasound in the kidney.

Authors:  Sean C Tenant; Catherine M Gutteridge
Journal:  Ultrasound       Date:  2016-01-19

Review 8.  The role of imaging in the active surveillance of small renal masses.

Authors:  P G K Wagstaff; P J Zondervan; J J M C H de la Rosette; M P Laguna
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

9.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

10.  Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis.

Authors:  Cong Wang; Chong Yu; Fang Yang; Guang Yang
Journal:  Tumour Biol       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.